Researchers identify shared molecular mechanism in cancer and pregnancy that suppresses immune system

Nivolumab plus ipilimumab or relatlimab nearly doubled response rates compared to nivolumab alone in head and neck cancer. Patients with major pathologic responses had better

ORLANDO – For people with inflammatory bowel disease (IBD), that hamburger may come with more than just a side of fries — red meat consumption